Emerald Advisers LLC Has $577,000 Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Emerald Advisers LLC raised its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 59.2% during the third quarter, Holdings Channel reports. The institutional investor owned 1,444 shares of the biotechnology company’s stock after buying an additional 537 shares during the quarter. Emerald Advisers LLC’s holdings in Axon Enterprise were worth $577,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. increased its holdings in Axon Enterprise by 987.5% during the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares in the last quarter. Quent Capital LLC boosted its position in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the last quarter. Asset Dedication LLC bought a new stake in Axon Enterprise during the second quarter worth $47,000. Friedenthal Financial purchased a new stake in Axon Enterprise in the 3rd quarter valued at $51,000. Finally, Cullen Frost Bankers Inc. bought a new position in Axon Enterprise during the 2nd quarter valued at $59,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $425.84 on Monday. Axon Enterprise, Inc. has a 12 month low of $209.02 and a 12 month high of $455.17. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. The stock has a market cap of $32.18 billion, a P/E ratio of 112.36, a P/E/G ratio of 10.78 and a beta of 0.94. The company has a 50 day moving average of $402.34 and a 200 day moving average of $340.86.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm’s revenue was up 34.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.80 earnings per share. As a group, sell-side analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the transaction, the president now owns 228,166 shares of the company’s stock, valued at $82,103,253.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the sale, the president now owns 228,166 shares of the company’s stock, valued at $82,103,253.44. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Jeri Williams sold 110 shares of the firm’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $400.00, for a total value of $44,000.00. Following the transaction, the director now directly owns 1,934 shares in the company, valued at approximately $773,600. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 371,172 shares of company stock worth $137,000,162. Insiders own 6.10% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on AXON shares. Needham & Company LLC upped their target price on shares of Axon Enterprise from $400.00 to $525.00 and gave the stock a “buy” rating in a research note on Tuesday, October 22nd. Barclays upped their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Robert W. Baird upped their target price on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a report on Tuesday, September 10th. JMP Securities increased their price target on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday. Finally, Northland Securities boosted their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $388.23.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.